Rocket Pharmaceuticals, Inc. also files under ITEK; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Wilson Martin | General Counsel | Sell(S) | 75K | $3.40 | $256K |
| Aug 18, 2026 | Shah Gaurav | CEO | Sell(S) | 2K | $3.38 | $8K |
| Aug 18, 2026 | Wilson Martin | General Counsel | Sell(S) | 631 | $3.38 | $2K |
| Aug 13, 2026 | Shah Gaurav | CEO | Sell(S) | 3K | $3.38 | $10K |
| Aug 13, 2026 | Wilson Martin | General Counsel | Sell(S) | 3K | $3.38 | $12K |
| Aug 11, 2026 | Stevens Christopher James | Chief Operating Officer | Sell(S) | 37K | $3.50 | $128K |
| Aug 11, 2026 | Chaudhuri Sarbani | See Remarks | Sell(S) | 5K | $3.50 | $16K |
| Aug 3, 2026 | Southwell David P | Director | Other(J) | 150K | — | $0 |
| Aug 3, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 101K | — | $0 |
| Aug 3, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 73K | — | $0 |
| Jun 18, 2026 | Boess Carsten | Director | Grant(A) | 65K | — | $0 |
| Jun 18, 2026 | Southwell David P | Director | Grant(A) | 65K | — | $0 |
| Jun 18, 2026 | Fong Peter | Director | Grant(A) | 23K | — | $0 |
| Jun 18, 2026 | Southwell David P | Director | Grant(A) | 23K | — | $0 |
| Jun 18, 2026 | Malik Fady Ibraham | Director | Grant(A) | 23K | — | $0 |
| Jun 18, 2026 | Boess Carsten | Director | Grant(A) | 23K | — | $0 |
| Jun 18, 2026 | Malik Fady Ibraham | Director | Grant(A) | 65K | — | $0 |
| Jun 18, 2026 | Dolsten Mikael | Director | Grant(A) | 65K | — | $0 |
| Jun 18, 2026 | Wong Roderick | Director, 10% Owner | Grant(A) | 28K | — | $0 |
| Jun 18, 2026 | Wong Roderick | Director, 10% Owner | Grant(A) | 79K | — | $0 |
| Jun 18, 2026 | Fong Peter | Director | Grant(A) | 65K | — | $0 |
| Jun 18, 2026 | Dolsten Mikael | Director | Grant(A) | 23K | — | $0 |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 50K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 18K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 27K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 10K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 29K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 20K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 10K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 10K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 25K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 18K | — | — |
| May 26, 2026 | Militello John | See Remarks | Grant(A) | 15K | — | — |
| May 26, 2026 | Militello John | See Remarks | Grant(A) | 25K | — | — |
| May 26, 2026 | Militello John | See Remarks | Grant(A) | 16K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 20K | — | — |
| May 26, 2026 | Militello John | See Remarks | Disposed to issuer(D) | 2K | — | — |
| May 26, 2026 | Militello John | See Remarks | Grant(A) | 52K | — | — |
| May 26, 2026 | Militello John | See Remarks | Grant(A) | 9K | — | — |
| May 21, 2026 | Shah Gaurav | CEO | Option exercise(M) | 76K | $1.69 | $129K |
| May 21, 2026 | Shah Gaurav | CEO | Sell(S) | 56K | $3.09 | $172K |
| May 21, 2026 | Shah Gaurav | CEO | Option exercise(M) | 76K | $1.69 | $129K |
| May 19, 2026 | Shah Gaurav | CEO | Sell(S) | 2K | $3.01 | $7K |
| May 19, 2026 | Militello John | See Remarks | Sell(S) | 384 | $3.01 | $1K |
| May 19, 2026 | Wilson Martin | General Counsel | Sell(S) | 662 | $3.01 | $2K |
| May 13, 2026 | Shah Gaurav | CEO | Sell(S) | 3K | $3.61 | $10K |
| May 13, 2026 | Wilson Martin | General Counsel | Sell(S) | 3K | $3.61 | $12K |
| May 13, 2026 | Militello John | See Remarks | Sell(S) | 855 | $3.61 | $3K |
| May 7, 2026 | Chaudhuri Sarbani | See Remarks | Sell(S) | 18K | $3.84 | $68K |
| Feb 18, 2026 | Militello John | See Remarks | Sell(S) | 1K | $3.34 | $4K |
| Feb 18, 2026 | Shah Gaurav | CEO | Sell(S) | 6K | $3.34 | $20K |
| Feb 18, 2026 | Wilson Martin | General Counsel | Sell(S) | 1K | $3.34 | $5K |
| Feb 13, 2026 | Militello John | See Remarks | Sell(S) | 4K | $3.31 | $12K |
| Feb 13, 2026 | Shah Gaurav | CEO | Sell(S) | 12K | $3.31 | $41K |
| Feb 13, 2026 | Wilson Martin | General Counsel | Sell(S) | 12K | $3.31 | $41K |
| Feb 11, 2026 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 93K | — | $0 |
| Feb 11, 2026 | Shah Gaurav | CEO | Grant(A) | 871K | — | $0 |
| Feb 11, 2026 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 62K | — | $0 |
| Feb 11, 2026 | Chaudhuri Sarbani | See Remarks | Grant(A) | 189K | — | $0 |
| Feb 11, 2026 | Shah Gaurav | CEO | Grant(A) | 286K | — | $0 |
| Feb 11, 2026 | Militello John | See Remarks | Grant(A) | 45K | — | $0 |
| Feb 11, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 93K | — | $0 |
| Feb 11, 2026 | Chaudhuri Sarbani | See Remarks | Grant(A) | 126K | — | $0 |
| Feb 11, 2026 | Militello John | See Remarks | Grant(A) | 30K | — | $0 |
| Feb 11, 2026 | Wilson Martin | General Counsel | Grant(A) | 468K | — | $0 |
| Feb 11, 2026 | Wilson Martin | General Counsel | Grant(A) | 312K | — | $0 |
| Feb 11, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 62K | — | $0 |
| Jan 2, 2026 | Bjork Elisabeth | Director | Buy(P) | 10K | $3.44 | $34K |
| Nov 18, 2025 | Shah Gaurav | CEO, Director | Sell(S) | 6K | $2.98 | $19K |
| Nov 18, 2025 | Wilson Martin | General Counsel | Sell(S) | 2K | $2.98 | $5K |
| Nov 18, 2025 | Militello John | See Remarks | Sell(S) | 1K | $2.98 | $3K |
| Nov 18, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 3K | $2.98 | $8K |
| Nov 3, 2025 | Wilson Martin | General Counsel | Grant(A) | 100K | — | $0 |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 6K | $3.97 | $22K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 3K | $3.97 | $12K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 558 | $3.98 | $2K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 20K | $3.96 | $79K |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 384K | — | $0 |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 283K | — | $0 |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Sep 24, 2025 | Fong Peter | Director | Grant(A) | 23K | — | $0 |
| Sep 24, 2025 | Fong Peter | Director | Grant(A) | 30K | — | $0 |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 59K | $3.11 | $183K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 1.0M | $3.11 | $3.1M |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 59K | $17.81 | $1.1M |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 41K | $3.11 | $128K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 41K | $19.09 | $783K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1.0M | $40.03as filed | — |
| Sep 8, 2025 | Militello John | See Remarks | Grant(A) | 40K | — | $0 |
| Sep 8, 2025 | Wilson Martin | General Counsel | Grant(A) | 150K | — | $0 |
| Sep 8, 2025 | Schwartz Jonathan David | See Remarks | Grant(A) | 80K | — | $0 |
| Aug 27, 2025 | Bjork Elisabeth | Director | Buy(P) | 10K | $3.41 | $34K |
| Aug 19, 2025 | Militello John | See Remarks | Sell(S) | 361 | $3.00 | $1K |
| Aug 19, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 805 | $3.00 | $2K |
| Aug 19, 2025 | Wilson Martin | General Counsel | Sell(S) | 588 | $3.00 | $2K |
| Aug 18, 2025 | Militello John | See Remarks | Sell(S) | 699 | $3.07 | $2K |
| Aug 18, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 2K | $3.07 | $5K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Rocket Pharmaceuticals, Inc., SEC CIK 0001281895. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RCKT and shows every filing by that issuer (also filed as ITEK).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RCKT